Table 2. Tumor incidence and latency period in mice receiving secondary xenografts.
| Group | Cells injected | Tumor incidence | Latency period(days) |
|---|---|---|---|
| Control | 5000 | 6/8 (75.0%) | 48 |
| DSF/5000 | 5000 | 7/8 (87.5%) | 42 |
| DSF/Cu/5000 | 5000 | 2/8 (25.0%) | 67 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.